AI Company GEDI Cube And Renovaro Biosciences Announce A Binding, Exclusive Letter Of Intent To Merge, Accelerating Fight Against Cancer; Terms Not Disclosed
$ENOB
$RENB
Biotechnology: Pharmaceutical Preparations
Health Care
Biotechnology: Pharmaceutical Preparations
Health Care
- Cutting-edge AI/machine learning technology with validation in humans for early diagnosis of lung cancer
- In silico detection for 12 additional cancers, including pancreatic
- More than 2,600 proprietary biomarker panels
- Rapidly expanding to other cancers and diseases
- Innovative biotechnology firm with promising pancreatic cancer results projected to begin human studies for several challenging solid tumors by mid-2024
- Combination creates potential multiplier effect to accelerate earlier diagnosis, more effective therapy, and precision, in silico drug discovery